Followers | 49 |
Posts | 2419 |
Boards Moderated | 0 |
Alias Born | 12/31/2014 |
Friday, August 07, 2020 8:19:15 AM
I have a few thoughts.
The run up before earnings is nothing new. Has happened every time for the past couple of years. I am still surprised when the masses see the selloff a day or two before the earnings are announced and say the sky is falling. Shoot, a smart short term investor would plan for it. Buy a week or two before earnings and sell a day or two before they are announced. Don't take my word for it, look at the charts for the past couple of years. Oh but that would mean someone would actually have to do some research.
As for NASDAQ .. yes the stock price needs to be higher but even when it was in line last year there were roadblocks. To my knowledge, those roadblocks are still there so a stock split would not have accomplished anything. Moot point as the stock split was voted down.
Uplisting to NASDAQ is a great idea and will open the doors to a lot of institutional investors, but it's not the sole answer for success. CVSI has plenty of hurdles to overcome. From what I can see they have made great strides.. cleaning house for example. I think the company as a whole is moving in the right direction but is years away from being the monolyth that a lot of us know they can be.
If you are in this to get rich quick then maybe you should buy that bridge that Chill has for sale in Arizona. Or at least stick to the quick move before earnings. Just my two cents.
A fool and his money is a friend indeed.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM